Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2003
07/03/2003WO2003054550A2 Uses of an endothelial cell receptor
07/03/2003WO2003054231A1 Method of examining allergic disease
07/03/2003WO2003054228A2 Human cellular enzymes as targets against hepatitis c virus infections
07/03/2003WO2003054197A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism
07/03/2003WO2003054195A1 Novel gene useful in diagnosing cancer and use thereof
07/03/2003WO2003054194A2 Modified tridegins, production and use thereof as transglutaminase inhibitors
07/03/2003WO2003054193A2 Raf/ras binding compounds
07/03/2003WO2003054187A1 Helicase gene
07/03/2003WO2003054165A2 Genetic markers and methods for the diagnosis, treatment and prevention of tumor metastasis
07/03/2003WO2003054158A2 Rapidly maturing fluorescent proteins and methods for using the same
07/03/2003WO2003054157A2 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents
07/03/2003WO2003054156A2 Novel g proein-coupled receptor, gave7
07/03/2003WO2003054154A2 Antisense modulation of mucin 1, transmembrane expression
07/03/2003WO2003054153A2 Apyrase polypeptides and nucleic acids encoding same
07/03/2003WO2003054152A2 Novel nucleic acids and polypeptides
07/03/2003WO2003054147A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
07/03/2003WO2003054146A2 Self-assembly and mineralization of peptide-amphiphile nanofibers
07/03/2003WO2003054144A2 Human ras interacting protein
07/03/2003WO2003054141A2 Sperm-specific cation channel, catsper2, and uses therefor
07/03/2003WO2003054015A2 Use of coagulant-active antitrhombin iii for the therapy of angiogenesis-dependent diseases
07/03/2003WO2003054012A2 Leptin proteins
07/03/2003WO2003054010A2 Early stage redox-related apoptosis modulator-2 (esram-2)
07/03/2003WO2003054009A2 Apoptotically active peptides
07/03/2003WO2003054007A2 Streptococcus antigens
07/03/2003WO2003054005A2 Bone polypeptide-1
07/03/2003WO2003054004A2 Secreted proteins
07/03/2003WO2003054002A1 Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumours
07/03/2003WO2003054001A2 Method for preparing echinocandin derivatives and their compositions
07/03/2003WO2003054000A1 Template-fixed peptidomimeticsas inhibitors of serine proteases
07/03/2003WO2003053999A2 Selective arylguanidine peptides as urokinase inhibitors
07/03/2003WO2003053997A2 Methods of increasing endogenous erythropoietin (epo)
07/03/2003WO2003053471A1 Aqueous sustained-release formulations of proteins
07/03/2003WO2003053468A1 Method for obtaining the elimination of integrated and functional viruses from infected mammal cells
07/03/2003WO2003053467A1 Drug for regenerating tissue and vessel and method therefor
07/03/2003WO2003053460A1 Crystalline compositions for controlling blood glucose
07/03/2003WO2003053459A2 Differential induction, maintenance and regulation of cd8+ t cell response against a model antigen expressed by an acute versus a chronic intracellular bacterium
07/03/2003WO2003053458A1 Use of a pharmaceutical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention
07/03/2003WO2003053457A1 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon
07/03/2003WO2003053455A1 Surfactant prevention of lung complications from cancer chemotherapy
07/03/2003WO2003053443A1 Substituted diketopiperazines as oxytocin antagonists
07/03/2003WO2003053413A2 Sustained-release compositions
07/03/2003WO2003053408A1 Liposomal tumor necrosis factor compositions
07/03/2003WO2003053405A1 Method and composition for dry eye treatment
07/03/2003WO2003053404A1 Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
07/03/2003WO2003053401A2 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
07/03/2003WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
07/03/2003WO2003053362A2 Systems and methods for treating patients with collagen-rich material extracted from adipose tissue
07/03/2003WO2003053360A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
07/03/2003WO2003053351A2 A NOVEL REGULATORY ELEMENT WITHIN THE IL-Iα PROMOTER AND USES THEREOF
07/03/2003WO2003053349A2 Inhibitors of hepatitis c virus
07/03/2003WO2003053347A2 Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
07/03/2003WO2003053346A2 Systems and methods for treating patients with processed lipoaspirate cells
07/03/2003WO2003053342A2 Antisense modulation of cd81 expression
07/03/2003WO2003053340A2 Antisense modulation of connective tissue growth factor expression
07/03/2003WO2003053339A2 Insulin molecule having protracted time action
07/03/2003WO2003053337A2 Therapeutic compositions
07/03/2003WO2003053336A2 Methods for the treatment of peripheral neural and vascular ailments
07/03/2003WO2003053334A2 Compositions and methods for the diagnosis and treatment of tumor
07/03/2003WO2003053332A2 Composition and method for treating viral infection
07/03/2003WO2003053325A2 Microencapsulation of drugs by solvent exchange
07/03/2003WO2003053220A2 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
07/03/2003WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003WO2003053158A2 Malleable protein matrix and uses thereof
07/03/2003WO2003031461A3 N-formyl peptide receptor mediation of platelet chemotaxis toward injured cells and activation of immune response
07/03/2003WO2003029488A3 A method for the early detection of cancer
07/03/2003WO2003028666A3 Isolated polypeptides and compositions from the venom of p. transvaalicus and methods of use
07/03/2003WO2003020201A3 Pre-mixes of glp-1 and basal insulin
07/03/2003WO2003018788A3 Improved nitroreductase enzymes
07/03/2003WO2003016499A3 Combinatorial methods for inducing cancer cell death
07/03/2003WO2003010284A3 Antisense modulation of c-reactive protein expression
07/03/2003WO2002101009A3 Structural and cytoskeleton-associated proteins
07/03/2003WO2002092014A3 Destruction of prions using vibriolysin or variants thereof
07/03/2003WO2002090991A3 Proteins and genes for diagnosis and treatment of erbb2-related cancer
07/03/2003WO2002090507A3 Oligonucleotide inhibitors of cancer cell proliferation
07/03/2003WO2002090495A8 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
07/03/2003WO2002081691A3 Abcg5 and abcg8: compositions and methods of use
07/03/2003WO2002076497A3 Method and composition
07/03/2003WO2002072616A3 Transfection complexes
07/03/2003WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor
07/03/2003WO2002070549A3 Chimeric polypeptides of serum albumin and uses related thereto
07/03/2003WO2002059604A3 Diagnosis and treatment of multiple sclerosis
07/03/2003WO2002058732A3 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
07/03/2003WO2002050279A3 Nucleic acid-associated proteins
07/03/2003WO2002046408A3 Human proteins, polynucleotides encoding them and methods of using the same
07/03/2003WO2002042776A3 Compositions and methods relating to prostate specific genes and proteins
07/03/2003WO2002040668A3 Proteins and dna sequences underlying these proteins used for treating inflammations
07/03/2003WO2002036761A3 Compositions and methods for the diagnosis of cancer
07/03/2003WO2002024888A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003WO2002024733A3 Human polynucleotides and polypeptides encoded thereby
07/03/2003WO2002022801A9 Mammalian receptor genes and uses
07/03/2003WO2002016599A3 Proteins and nucleic acids encoding same
07/03/2003WO2002006317A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/03/2003WO2001098365A3 Peptide and polypeptide inhibitors of complement c1s
07/03/2003WO2001083750A9 Dendritic cell co-stimulator molecules
07/03/2003US20030126625 Transgenic roundworm for monitoring inhibitors of protein secretion pathways; parasiticides; disease resistant plants
07/03/2003US20030125657 Comprises ligand for human immunoglobulin for immunoapheresis, which mimicks sequence of an adrenergic receptor structure
07/03/2003US20030125615 Homing of autologous cells to a target zone in tissue using active therapeutics or substances
07/03/2003US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder
07/03/2003US20030125540 Cytokine thymotaxin; tumor necrosis factor receptors; connective tissue growth factor; huchordin; embryonic development; inhibitor of myeloid or lymphoid progenitor cell proliferation
07/03/2003US20030125538 Amino acid transporters and uses
1 ... 1816 1817 1818 1819 1820 1821 1822 1823 1824 1825 1826 1827 1828 1829 1830 1831 1832 1833 1834 1835 1836 ... 3163